Skip to content

Diode laser and Iontophoresis with 2% NaF in the management of Dentinal hypersensitivity

Efficacy Comparison of the Diode Laser and Iontophoresis with 2% NaF in the management of Dentinal hypersensitivity: An in- vivo study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068158
Enrollment
80
Registered
2024-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: Diode laser: Biolase epicx diode laser Power- 1.5W pulsed (50% duty cycle) Diode laser will be applied perpendicular to the long axis of the tooth in a non-contact mode for 90 seconds,

Sponsors

Dr Disha Hirani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) An age limit between 20 and 50 years, irrespective of the gender. 2) Patients having sensitive permanent teeth surfaces [buccal/facial aspects of incisors, canines, or premolars] with wasting diseases and/or gingival recession having sensitivity to air blast/ visual analog scale score (VAS) = 3 and =6. 3) No history of periodontal therapy in the previous 3 months. 4) Good systemic health of the selected patients with clinically elicitable DH.

Exclusion criteria

Exclusion criteria: 1).Currently undergoing desensitizing treatment. 2). Caries, Pulp pathologies, defective restorations,fracture 3). Chronic severe periodontal disease. 4). Uncontrolled systemic diseases. 5).patients having pacemakers. 6).Pregnant and/or lactating women. 7). Usage of analgesic, anticonvulsants, sedatives, tranquilizers, and anti inflammatory drugs within 72 h.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is to evaluate reduction in VAS scoreTimepoint: baseline, immediately after the treatment, 1 week, 1 and 3 months of the recall period.

Secondary

MeasureTime frame
reduction in tactile sensitivityTimepoint: baseline, immediately after the treatment, 1 week, 1 and 3 months of the recall period.

Countries

India

Contacts

Public ContactDr Disha Hirani

Hitkarini Dental College & Hospital, Jabalpur, Madhya Pradesh

shivmantri24@gmail.com9425832314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026